Biography of Frankie Rose
Courses taught at Union:
Advanced Human Physiology, Advanced Human Anatomy, Medical Physiology, Clinical Pathophysiology, Professional Shadowing, Medical Genetics, Medical Literature Review, and Master's Research Seminar.
Students in my lab study the small genetic differences between individuals, specifically Single Nucleotide Polymorphisms (SNPs).
Here is a link to our most recent publication:
Fernando, J., Carlson, B., LeBard, T., McCarthy, M., Umali, F., Ashton, B., & Rose, F. F. (2015). A Laboratory Exercise for Genotyping Two Human Single Nucleotide Polymorphisms. Journal of Biological Education
Postdoctoral Research, University of Missouri (2009-2010)
Field of Study: Development of gene therapy vectors for the treatment of Spinal Muscular Atrophy (SMA)
Ph.D. Microbiology, University of Missouri (2005- 2009)
Field of Study: Molecular Genetics of Spinal Muscular Atrophy (SMA)
Medical Student/Elective Research Studies, Kirksville College of Osteopathic Medicine (2002- 2005)
B.S. Biology, Union College (1997- 2002)
High School Diploma, Sunnydale Academy (1994-1997)
Rose, F.F., Meehan, P.W., Coady, T.H., Garcia, V.B., Garcia, M.L., and Lorson, C.L. (2008). The Wallerian degeneration slow (Wlds) gene does not attenuate disease in a mouse model of spinal muscular atrophy. Biochemical and Biophysical Research Communications.
Ebert, A.D., Yu, J., Rose, F.F., Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280.
Rose, F.F., Mattis, V.B., Rindt, H., and Lorson, C.L. (2009). Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 18, 997–1005.
Butchbach, M.E.R., Rose, F.F., Jr, Rhoades, S., Marston, J., McCrone, J.T., Sinnott, R., and Lorson, C.L. (2010). Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy. Biochem. Biophys. Res. Commun. 391, 835–840.
Glascock, J.J., Osman, E.Y., Coady, T.H., Rose, F.F., Shababi, M., and Lorson, C.L. (2011). Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J Vis Exp.
Dale, J.M., Shen, H., Barry, D.M., Garcia, V.B., Rose, F.F., Lorson, C.L., and Garcia, M.L. (2011). The spinal muscular atrophy mouse model, SMAΔ7, displays altered axonal transport without global neurofilament alterations. Acta Neuropathol 122, 331–341.
Rindt, H., Buckley, D.M., Vale, S.M., Krogman, M., Rose, F.F., Jr, Garcia, M.L., and Lorson, C.L. (2012). Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy. Neuromuscul. Disord. 22, 277–285.
Cobb, M.S., Rose, F.F., Rindt, H., Glascock, J.J., Shababi, M., Miller, M.R., Osman, E.Y., Yen, P.-F., Martin, B.R., Wetz, M.J., et al. (2013). Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy. Hum. Mol. Genet.